Bcl-3 siRNA (h) from Santa Cruz Biotechnology, Inc.

Product Specs
ItemBcl-3 siRNA (h)
CompanySanta Cruz Biotechnology, Inc.
Price $293.00Supplier Page View Company Product Page
Catalog Numbersc-29789
Gene NameB-cell CLL/lymphoma 3
Quantity10 µM
Specieshuman
NCBI Full Gene NameBCL3 transcription coactivator
NCBI Gene AliasesBCL4, D19S37
TypesiRNA/dsRNA

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) The proto-oncogene Bcl3 induces immune checkpoint PD-L1 expression, mediating proliferation of ovarian cancer cellsThe Journal of biological chemistryOctober 5, 2018Zou Y, Uddin MM, Padmanabhan S, Zhu Y, Bu P, Vancura A, Vancurova I.

(2) Hirsutine induces mPTP-dependent apoptosis through ROCK1/PTEN/PI3K/GSK3β pathway in human lung cancer cellsCell death & diseaseMay 22, 2018Zhang R, Li G, Zhang Q, Tang Q, Huang J, Hu C, Liu Y, Wang Q, Liu W, Gao N, et al.

(3) The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21)The Journal of pathologyFebruary 1, 2017Kuo SH, Tsai HJ, Lin CW, Yeh KH, Lee HW, Wei MF, Shun CT, Wu MS, Hsu PN, Chen LT, et al.

(4) B-cell CLL/lymphoma 3 promotes glioma cell proliferation and inhibits apoptosis through the oncogenic STAT3 pathwayInternational journal of oncologyDecember 1, 2016Wu J, Li L, Jiang G, Zhan H, Wang N.

(5) BCL-3 promotes the tumor growth of hepatocellular carcinoma by regulating cell proliferation and the cell cycle through cyclin D1Oncology reportsApril 1, 2016Tu K, Liu Z, Yao B, Xue Y, Xu M, Dou C, Yin G, Wang J.

(6) BCL3 exerts an oncogenic function by regulating STAT3 in human cervical cancerOncoTargets and therapyJanuary 1, 2016Zhao H, Wang W, Zhao Q, Hu G, Deng K, Liu Y.

(7) Bcl3 regulates pro-survival and pro-inflammatory gene expression in cutaneous T-cell lymphomaBiochimica et biophysica actaNovember 1, 2014Chang TP, Vancurova I.(final concentration) of control siRNA-A (sc-37007; Santa Cruz Biotechnology, CA, USA) or Bcl3 siRNA (sc-29789) was used. Cells were transfected with TransIT-siQUEST transfection reagent (Mirus Bio, Madison, WI,

(8) Knockdown of Bcl-3 inhibits cell growth and induces DNA damage in HTLV-1-infected cellsAsian Pacific journal of cancer prevention : APJCPJanuary 1, 2013Gao C, Wang X, Chen L, Wang JH, Gao ZT, Wang H.

(9) Bcl-3 suppresses Tax-induced NF-κB activation through p65 nuclear translocation blockage in HTLV-1-infected cellsInternational journal of oncologyJanuary 1, 2013Wang J, Li J, Huang Y, Song X, Niu Z, Gao Z, Wang H.

(10) Bcl-3 acts as an innate immune modulator by controlling antimicrobial responses in keratinocytesThe Journal of investigative dermatologySeptember 1, 2009Büchau AS, MacLeod DT, Morizane S, Kotol PF, Hata T, Gallo RL.

(11) Bcl-3-regulated transcription from major immediate-early promoter of human cytomegalovirus in monocyte-derived macrophagesJournal of immunology (Baltimore, Md. : 1950)June 15, 2009Khan KA, Coaquette A, Davrinche C, Herbein G.

Be the First to Write a Review!

Bcl-3 siRNA (h)

Bcl-3 siRNA (h) from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (11)

Reviews

Bcl-3 siRNA (h) from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map